NCNA
NuCana PLC
NASDAQ: NCNA · HEALTHCARE · BIOTECHNOLOGY
$2.13
+4.41% today
Updated 2026-04-30
Market cap
$9.20M
P/E ratio
0.00
P/S ratio
—
EPS (TTM)
$0.00
Dividend yield
—
52W range
$1 – $250
Volume
0.0M
NuCana PLC (NCNA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-193.90%
ROA
-58.30%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-6173.00 | — | — | — |
| 2015 | $0.00 | $-5.33M | — | — | — |
| 2016 | $0.00 | $-6.05M | — | — | — |
| 2017 | $283000.00 | $-23.09M | 100.00% | -7,860.78% | -8,157.24% |
| 2018 | $0.00 | $-13.84M | — | — | — |
| 2019 | $0.00 | $-21.41M | — | — | — |
| 2020 | $0.00 | $-30.68M | — | — | — |
| 2021 | $0.00 | $-40.53M | — | — | — |
| 2022 | $0.00 | $-32.02M | — | — | — |
| 2023 | $0.00 | $-27.63M | — | — | — |
| 2024 | $0.00 | $-19.00M | — | — | — |
| 2025 | $0.00 | $-28.71M | — | — | — |